“[W]e are losing the global fight against bad medicines,” and though “[s]ome progress is being made,” the “problem is that … crackdowns tend to focus on counterfeit drugs” while a “much bigger public health problem … is substandard drugs that are the result of shoddy manufacturing and handling — or perhaps worse, deliberate corner-cutting,” Roger Bate, a resident scholar at the American Enterprise Institute, writes in an opinion piece in The Hill’s “Congress Blog.” He continues, “In poor countries, a frightfully high number of bad drugs reach patients through legitimate supply chains and even donor programs underwritten by U.S. and European taxpayers,” increasing the risk of harm to patients and the development of drug-resistant disease strains.
Vaccines “save lives by protecting people against disease,” but they “also are an engine for economic growth — far beyond their health benefits,” GAVI Alliance CEO Seth Berkley writes in a CNN opinion piece. GAVI and its “many partners, including prominent companies,” “recognize that in addition to the humanitarian need, countries such as Tanzania are emerging markets that can fulfill their economic ambitions only if they also can ensure good health for their citizens,” he states. Berkley describes efforts to increase vaccination rates in Tanzania, and he writes, “[W]e know for a fact that vaccines — in addition to saving lives and improving health — are the cornerstone of a vibrant economy, fuel growth and serve as a magnet for foreign investment. Indeed, research has shown vaccines to be among the most cost-effective investments in global development.”
“After three decades of global emergency responses and a series of scientific breakthroughs in the fight against HIV/AIDS, it is now tempting to ask if we are marching towards the end of AIDS,” an editorial in the Lancet states. Noting the November 29 release of the U.S. Government’s PEPFAR Blueprint: Creating an AIDS-Free Generation, the Lancet writes, “The first and foremost signal the report has sent is that the U.S. commitment to the global AIDS response will continue to be ‘strong, comprehensive and driven by science,'” and the report “calls on partner countries, civil society, donors, foundations, multilateral institutions, and people living with HIV to step up together and make concrete commitments.” The editorial continues, “The vision of ‘an AIDS-free generation’ in the blueprint relies heavily on scientific and technological feasibility … However, eradicating a disease goes far beyond scientific advances, which will go unrealized without strong social support and public health actions as well as substantial and sustainable investments.”
The “progress and momentum” behind stopping mother-to-child HIV transmission is “reason to celebrate,” Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, and Peter Twyman, CEO of Keep a Child Alive, write in The Hill’s “Congress Blog.” However, “as we set our sights on an AIDS-free generation, we must once again ensure that children currently living with HIV are not left behind,” they state. “Unfortunately, we’re not seeing the same level of progress with access to services for children who are already living with the virus,” they write and describe the challenges children and their families face in gaining access to HIV treatment and care, including stigma and fear and a lack of antiretroviral drug formulations for children.
Chris Endean of the GAVI Alliance writes ahead of the GAVI Partners Forum in a CNN opinion piece about efforts to vaccinate members of the Maasai tribes in Tanzania’s Arusha National Park. Noting Maasai tribes are “constantly on the move searching for water and fresh pasture for their cattle,” he describes “severe logistical challenges” health workers face when trying to reach their patients and notes, “The need to get to hard-to-reach people like the Maasai and the rest of the estimated eight percent of Tanzania’s population that do not receive basic life-saving vaccines has taken on a new urgency with the country’s recent launch of a five-year development plan” called the “One Plan.” Endean notes the forum is taking place in the country’s capital, Dar es Salaam, and that during the event, “the health ministry will launch two new vaccines into the national immunization program — pneumococcal and rotavirus — tackling the primary causes of pneumonia and diarrhea — two of the leading killers of under-fives in Tanzania” (12/5).
Noting that the WHO’s Global Tuberculosis Report shows “that access to care and treatment for tuberculosis [TB] has expanded substantially in the past two decades,” Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes in an AlertNet opinion piece, “Not only is this good news for those countries that are most vulnerable to tuberculosis; it is also good news for the global community,” as TB can be passed through the air. Derrick describes some of the interventions against TB instituted internationally, and she notes the Global Fund to Fight AIDS, Tuberculosis and Malaria “is the largest global donor to tuberculosis programs, providing 82 percent of international funding to fight the disease,” as well as “91 percent of international financing” to fight multidrug-resistant TB (MDR-TB).
Through travel to Africa and “[a]s chairman and ranking member of the Senate Foreign Relations Subcommittee on African Affairs, we’ve seen firsthand the enormous toll of HIV/AIDS on families, communities and economies,” Sen. Chris Coons (D-Del.) and Sen. Johnny Isakson (R-Ga.) write in the Huffington Post’s “Politics” blog. “On December 1st, we marked World AIDS Day by honoring the lives lost to the scourge of AIDS and by recommitting ourselves to building an AIDS-free generation and ending this pandemic once and for all,” they write, adding, “Although we come from different political parties, we stand together in our belief that the United States should remain a global leader in the fight against HIV/AIDS.”
In the New York Times’ “Scientist At Work” blog, Alexander Kumar, a physician and researcher at Concordia Station in Antarctica, examines the question of “why humans should venture out to other planets, and perhaps in the process create new problems, when we have so many problems on our own planet,” including HIV, malaria, tuberculosis and other “largely preventable and treatable” conditions. Kumar, who is “investigat[ing] the possibility of one day sending humans to Mars” for the European Space Agency, says he is “repeatedly asked … why the human race would invest its precious and finite resources (money) into space exploration?” He continues, “People have presented valid arguments both ways: those against, about depriving the bottom billion of our planet by diverting much-needed funding; and those in favor, for furthering mankind’s now-desperate need for discoveries and new life-saving technology through exploration in space.
“Global health is changing — both in policy and practice,” Alanna Shaikh, a development consultant and blogger currently working on a USAID-funded health project, writes in an opinion piece in the Guardian’s “Global Development Professionals Network” blog, adding the field is getting “far more attention in the past decade than in the years before,” which “also creates challenges.” Finding ways to prioritize resources and issues can be difficult, she says, but using the “global health perspective is valuable across the board” because it “focuses on linkages — between individuals, communities and nations, and among health topics.”
The Skoll World Forum and the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog have co-produced a blog series to answer the question, “What will it really take to end AIDS?” In the first of six posts, Steffano Bertozi, director of HIV in the Gates Foundation’s Global Health Program, writes, “[D]espite evidence of measurable progress, it’s important to recognize that we still don’t have all of the tools that we need to end AIDS,” therefore “we still have an essential moral obligation to discover, develop and deliver new and better ways to help people protect themselves from HIV infection” (12/3). In another post, Erin Hohlfelder, ONE’s policy manager for health, says with “scaled-up financing, targeted programming, and expanded political will,” as well as “renewed urgency and concerted action, the world can transform the beginning of the end of AIDS from a vision to a reality and chart a course towards ending this pandemic” (12/3).